Yahoo Malaysia Web Search

Search results

1. www.astrazeneca.comAstraZeneca - Research-Based BioPharmaceutical Company

   www.astrazeneca.com

   • Cached

   Jun 17, 2024 · AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.

   • Thailand

     AstraZeneca Thailand has operated for almost 40 years and,...

   • Farxiga Approved in The US

     AstraZeneca’s Farxiga (dapagliflozin) has been approved by...

   • Collaboration in Cell Therapy Regulation

     Simplified regulatory pathways will ensure that development...

2. www.astrazeneca.com › media-centre › press-releasesUpdate on the CAPItello-290 Phase III trial for Truqap plus ...

   www.astrazeneca.com › media-centre › press-releases

   • Cached

   Jun 18, 2024 · Update on the CAPItello-290 Phase III trial for Truqap plus chemotherapy in advanced or metastatic triple-negative breast cancer. PUBLISHED 18 June 2024. The CAPItello-290 Phase III trial for Truqap (capivasertib) in combination with paclitaxel in patients with locally advanced (inoperable) or metastatic triple-negative breast cancer (TNBC) did ...

3. Top stories

   • 

     Indiatimes

     AstraZeneca to invest Rs 250 crore on expansion of its GCC in India

     3 days ago

   • 

     VietnamPlus

     K Hospital, AstraZeneca Vietnam collaborate to enhance cancer research, treatment

     14 hours ago

   • 

     Daily

     AstraZeneca Pharma India gets CDSCO Panel Nod to study anti-cancer drug Datopotamab deruxtecan/Rilvegostomig

     11 hours ago

   • Entrepreneur

     AstraZeneca to Invest INR 250 Cr to Expand Its Chennai Global Innovation and Tech Centre

     Minister of Industries Dr TRB Rajaa, Govt of Tamil Nadu, Christina Scott CMG, Deputy British High Commissioner to India and AstraZeneca team at the inauguration of expanded GCC space in Chennai AstraZeneca India Private Limited (AZIPL) has announced an INR ...

     2 days ago

   • health.economictimes.indiatimes

     AstraZeneca India to invest Rs 250 crore to expand its Global Innovation and Technology Centre

     3 days ago

   View all

4. www.astrazeneca.com › media-centre › press-releasesCalquence plus chemoimmunotherapy reduced the risk of disease ...

   www.astrazeneca.com › media-centre › press-releases

   • Cached

   Jun 16, 2024 · Results showed the Calquence combination regimen reduced the risk of disease progression or death by 27% compared to standard-of-care chemoimmunotherapy (hazard ratio [HR] 0.73; 95% confidence interval [CI] 0.57-0.94; p=0.016).

5. www.britannica.com › topic › AstraZenecaAstraZeneca | Pharmaceuticals, Vaccines, & Facts | Britannica

   www.britannica.com › topic › AstraZeneca

   • Cached

   5 days ago · AstraZeneca, British-Swedish biopharmaceutical company with medicine sales in more than 130 countries, making it one of the largest drug companies in the world. AstraZeneca’s main research and development areas include oncology, rare diseases, and biopharmaceutical intervention, and it has numerous.

6. data.moh.gov.my › dashboard › covid-vaccinationCOVID-19 Vaccination · Malaysia | KKMNOW

   data.moh.gov.my › dashboard › covid-vaccination

   3 days ago · 0.3 %. Building on the Ministry of Health's previous COVIDNOW dashboard, this page provides a summarised view of the COVID-19 vaccination program in Malaysia, allowing you to track its evolution on a daily basis.

7. www.verywellhealth.com › astrazeneca-oxford-covid-19-vaccineAstraZeneca-Oxford COVID-19 Vaccine: What You Need to Know

   www.verywellhealth.com › astrazeneca-oxford-covid-19-vaccine

   • Cached

   Jun 27, 2024 · While some vaccine makers used newer approaches to fight COVID-19, others turned to more established methods. The pharmaceutical company AstraZeneca partnered with Oxford University to develop an adenovirus-based vaccine, officially named ChAdOx1 nCoV-19 (AZD1222). The vaccine is a viral vector vaccine.

8. www.ft.com › content › 9b2238eb-0a5b-4315-bc57-c4f74ce1ce37AstraZeneca’s next big target can cement its sector darling...

   www.ft.com › content › 9b2238eb-0a5b-4315-bc57-c4f74ce1ce37

   • Cached

   Jun 10, 2024 · Pharma group believes successful medicines from its clinical trials could generate $20bn in revenue by 2030. Half of the 20 new medicines AstraZeneca expects to launch by the end of the decade ...